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A complex, which consists of ERCC1 (38 kDa) and a
112-kDa protein, was purified from HeLa cells to homo-
geneity. This complex complemented the nucleotide ex-
cision repair defects of rodent ERCC-1, ERCC-4, and
human XP-F mutant cell-free extracts, indicating that
the 112-kDa protein is XPF/ERCC4 and providing direct
biochemical evidence that XPF and ERCC4 are identi-
cal. The XPF/ERCC4-ERCC1 complex has an endonucle-
ase activity with preference for single-stranded DNA
and a single-stranded region of duplex DNAwith a “bub-
ble” structure. This complex also nicks supercoiled DNA
weakly, and this nicking activity is stimulated by human
replication protein A when the DNA contains UV
damage.
Xeroderma pigmentosum (XP)1 is a human disease charac-
terized by a high incidence of actinic cancers and in some cases
neurological abnormalities; it is caused by a defect in excision
repair as a result of mutations in one of seven genes, XPA
through XPG (1). In recent years all of the XP genes required
for excision, with the exception of XPF, have been cloned and
sequenced (2, 3). Previously it was found that cell-free extracts
(CFEs) from human XP-F and rodent ERCC-4 mutants did not
complement each other in vitro, raising the possibility that
these two complementation groups contained mutations in the
human and rodent homologs of the XPF gene (4, 5). In addition,
it was found that the complementing activity of XP-F and
ERCC-4 mutant CFEs was tightly associated with the ERCC1
protein (6–8). Here we report the purification of the XPF/
ERCC4 protein in complex with ERCC1 to homogeneity, pro-
viding direct evidence that XPF and ERCC4 are identical
genes. The tight complex of XPF/ERCC4 and ERCC1 is a sin-
gle-stranded DNA-specific endonuclease with weak endonu-
cleolytic activity on supercoiled DNA. The nicking of super-
coiled DNA is stimulated by human replication protein A (RPA)
when the DNA contains UV damage.
MATERIALS AND METHODS
Purification of the Complex of ERCC1 and XPF/ERCC4 from HeLa
Cells—All purification procedures were done at 0–4 °C. HeLa whole
cell extracts were prepared from a 400-liter culture containing approx-
imately 2.5 3 1011 cells (about 35 g of protein) as described previously
(7). ERCC1-containing fractions were detected by immunoblotting us-
ing polyclonal antibodies raised against maltose-binding protein-
ERCC1 fusion protein expressed in Escherichia coli (6). The HeLa cell
extracts were applied to a DE52 column (5 3 21 cm, Whatman) as
described (7). The ERCC1 protein was in the flow-through, which was
applied to an Affi-Gel Blue column (5 3 18 cm, Bio-Rad) pre-equili-
brated with buffer A (25 mM HEPES-KOH, pH 7.9, 100 mM KCl, 12 mM
MgCl2, 0.5 mM EDTA, 2 mM dithiothreitol, 15.5% glycerol). The bound
proteins were eluted with a linear 800-ml gradient of 0.1–0.7 M KCl,
with 1.2 liters of buffer A plus 0.8 M KCl, and then with 500 ml of buffer
A plus 1.5 M NaSCN. Fractions containing ERCC1 protein were pooled,
and ammonium sulfate was added to 0.6 g/ml. Precipitated proteins
were pelleted by centrifugation at 15,000 3 g for 1 h, resuspended in 50
ml of buffer B (25 mM HEPES-KOH, pH 7.6, 1 mM EDTA, 10 mM
b-mercaptoethanol, 10% glycerol), and dialyzed against the same
buffer. The dialysate was applied to a 6-ml glutathione S-transferase-
XPA protein affinity column pre-equilibrated with buffer B, washed
with the same buffer, and eluted with buffer B plus 0.9 M KCl. The pool
of ERCC1 fraction (48 ml) was concentrated to 1.6 ml using Centriprep
30 (Amicon), dialyzed against buffer A, and applied to a 4-ml DEAE-
Sepharose column (Sigma). The flow-through fractions containing
ERCC1 protein were pooled and loaded onto a 2-ml heparin-agarose
column (Sigma). The bound proteins were eluted with buffer A plus 0.9
M KCl. The final pool of ERCC1 fraction (2.4 mg) was concentrated using
Centricon 30 (Amicon), dialyzed against buffer A, and stored at 280 °C.
In Vitro Excision Assay—The human excinuclease activity was tested
by in vitro excision assay using the 140-base pair (bp) substrate con-
taining a cholesterol adduct in the center and a 32P label at the sixth
phosphodiester bond 59 to the lesion as described previously (7). The
repair reaction mixture (25 ml) contained 35 mM HEPES-KOH, pH 7.9,
10 mM Tris-HCl, pH 7.5, 50 mM KCl, 20 mM NaCl, and 5.6 mM MgCl2,
0.4 mM EDTA, 0.8 mM dithiothreitol, 6.8% glycerol, 2 mM ATP, 20 mM
dNTPs, 100 mg/ml bovine serum albumin, ;1 nM substrate, and 50 mg
of CFEs. In complementation assays with CFEs, 25 mg of each of two
mutant CFEs was included in the reaction mixture. The reaction mix-
ture was incubated for 1 h at 30 °C, and the excision products were
analyzed by electrophoresis in 10% denaturing polyacrylamide gels.
Endonuclease Assay—Covalently closed single-stranded M13 mp19
DNA (125 ng) or covalently closed supercoiled double-stranded
pMLU112 DNA (100 ng) was incubated at 37 °C for the indicated time
in 15 ml of nuclease reaction buffer (25 mM HEPES-KOH, pH 7.9, 25 mM
KCl, 3 mM MgCl2, 1 mM dithiothreitol, 120 mg/ml bovine serum albu-
min, and 6.5% glycerol) with the XPF-ERCC1 complex. After incuba-
tion, the reaction was terminated with 1% SDS. Samples were analyzed
by electrophoresis at 80 V for 1.5 h on 1% agarose gels, followed by
staining DNA with ethidium bromide and photography. To test the
effect of RPA on XPF-ERCC1 endonuclease activity, non-irradiated or
UV-irradiated pMLU112 DNA (100 ng) was incubated with 20 ng of the
single-stranded DNA binding proteins from different sources and 165
ng of XPF-ERCC1 fraction from the XPA-affinity column step for 20 min
at 30 °C and analyzed as described above.
Endonuclease Assay for a Linear Duplex DNA Containing a Bubble
Structure—The 59-labeled bubble substrate was prepared by labeling
the oligonucleotide 59-CCTGCCTAGGATCCAGTAGTCGACTTGGA-
CGAACCCGGGATGGAATGGAGTATTCGCCGTGTCCATGGCTGTA-
AGTATCCAGGATCCCGG-39 using T4 polynucleotide kinase and
[g-32P]ATP, followed by annealing to the oligonucleotide
59-CCGGGATCCTGGATACTTACAGCCATATCAGTTACGCCAGTAT-
GCCGATGCTATAAGTTCGTCCAAGTCGACTACTGGATCCTAGGC-
AGG-39. Unpaired regions are underlined. The 90-bp duplex DNA (;1
nM) containing a bubble of 30 nucleotides was incubated for 3 h at 37 °C
with the purified XPF-ERCC1 complex as described above. After incu-
bation, 0.1 volume of 0.25 M EDTA and 1 volume of formamide-dye were
added to the reaction mixture, and the products were analyzed using a
10% denaturing polyacrylamide gel. S1 nuclease digestion was carried
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out at 20 °C for 20 min in 30 mM sodium acetate (pH 4.6), 1 mM zinc
acetate, 50 mM NaCl, and 5% glycerol with 0.1 unit of S1 nuclease (Life
Technologies, Inc.).
Immunodepletion of the XPF-ERCC1 Complex by Anti-ERCC1 Anti-
body—Protein A-agarose beads (30 ml, Santa Crutz) were incubated
with 60 ml of preimmune serum or immune serum raised against
ERCC1 protein for 1 h at 4 °C. The beads were washed extensively with
buffer A and incubated with 1.3 mg of XPF-ERCC1 fraction from the
XPA-affinity column step for 1 h at 4 °C. After spinning down the beads,
the supernatant was carefully removed and used in the endonuclease
assay with single-stranded M13 DNA.
Quantitation of the Endonuclease Activity—The intensities of DNA
bands were measured by scanning the photographs of ethidium
bromide-stained agarose gels with a Molecular Dynamics computing
densitometer series 300 instrument, and the average numbers of the
nicks per DNA molecule were calculated by the P(0) class of Poisson
distribution.
RESULTS AND DISCUSSION
Purification of XPF/ERCC4 in the Complex with ERCC1
from HeLa Cell-free Extract—The ERCC1-containing complex
was purified from 400 liters of HeLa cell culture using proce-
dures modified from Mu et al. (7) in which an XPA-affinity
chromatography is the major purification step, since XPA pro-
tein binds to ERCC1 protein with high affinity (6, 9). The
affinity-purified complex was purified further through two ad-
ditional columns, DEAE-Sepharose followed by heparin-agar-
ose, and only two polypeptides were detected in the final frac-
tion by silver staining (Fig. 1, lane 1). One is at 38 kDa and was
identified as ERCC1 based on the calculated molecular weight
from the cDNA sequence (10) and Western blotting with anti-
ERCC1 antibodies (Fig. 1, lane 2). The other protein has an
apparent molecular mass of 112 kDa.
It was recently reported that partially purified ERCC1 frac-
tions complemented both XP-F and ERCC-4 CFEs as well as
ERCC-1 CFE (7, 8), raising the possibility that the 112-kDa
protein, which makes a complex with ERCC1, is XPF and/or
ERCC4. The purified complex was tested for complementing
CFEs of mutant cell lines for excision activity (Fig. 2). As
expected, the complex complemented rodent ERCC-1 mutant
extract (lane 6). In addition, the complex complemented XP-F
and ERCC-4 CFEs as well (lanes 4 and 10), while no other
mutant extract (XP-A, ERCC-3 (XP-B), and ERCC-5 (XP-G))
was complemented (lanes 2, 8, and 12). Furthermore, the
complementation of both XP-F and ERCC-4 CFEs by the com-
plex was inhibited by anti-ERCC1 antibodies (data not shown).
This inhibition was overcome by the addition of the excess
amount of the purified complex, indicating that both comple-
mentations were due to the ERCC1-containing complex but not
to a minor contaminant in our preparation. These results lead
us to conclude that the 112-kDa protein is XPF, which in turn
is identical to ERCC4. Previously, it was found that CFEs from
human XP-F and rodent ERCC-4 mutants did not complement
each other in vitro for either excision (4) or repair synthesis (5,
11) activity, and it was suggested that the ERCC4 gene might
be identical to the XPF gene or that XPF-ERCC1 was in a
complex with ERCC4 (4, 5, 11). Here we show direct biochem-
ical evidence that XPF and ERCC4 are identical,2 in spite of
earlier evidence based on somatic cell hybrids suggesting that
ERCC4 and XPF might be different genes (12).
XPF-ERCC1 Complex Is a Single-stranded DNA Endonucle-
ase—Since it is known that the presumed yeast homolog of
XPF-ERCC1, the RAD1-RAD10 complex, is an endonuclease
with a specificity for single-stranded DNA and supercoiled
double-stranded DNA (13, 14), we tested the XPF-ERCC1 com-
plex for nuclease activity. Fig. 3, A and B, shows that the
complex degraded single-stranded M13 DNA extensively and
nicked supercoiled DNA rather inefficiently with no preferen-
tial activity on UV-damaged DNA. These data are consistent
with XPF-ERCC1 being a single strand specific endonuclease.
The nuclease activity is dependent on Mg21, which can be
replaced by Mn21 but not by Ca21, Co21, Cu21, and Zn21 (data
not shown). To confirm that the nuclease activity was intrinsic
to XPF-ERCC1, the fractions from the last purification column
were tested for XPF-ERCC1 by Western blotting with anti-
ERCC1 antibodies and for nuclease activity using M13 DNA as
a substrate. Fig. 3C shows co-elution of ERCC1 (and hence the
complex) and of nuclease activity. When fraction 24 containing
the nuclease activity was analyzed by silver staining, it con-
tained only two proteins, ERCC1 and XPF (Fig. 1, lane 1).
Furthermore, the nuclease activity was partially suppressed by
immunodepletion of the XPF-ERCC1 complex with anti-
ERCC1 antibodies (Fig. 3D), consistent with the notion that the
endonuclease activity is intrinsic to the XPF-ERCC1 complex.
It has been reported that RAD1-RAD10 specifically cleaves
the single strand to double strand junction of Y-shaped DNA
only of the strand with the 39 single-stranded terminus, and
hence the preferential nuclease activity on single-stranded
M13 DNA by the RAD1-RAD10 complex was attributed to
cleavage at the junction of stem-loop structures known to exist
in M13 DNA (15). To test for such an activity, we designed a
90-bp partial duplex DNA with a 30-nucleotide “bubble” near
the center because of non-complementary sequences. As shown
in Fig. 4A, the homogeneous fraction containing only the XPF
and ERCC1 proteins (Fig. 1) did not show such a preference;
rather a ladder in the region corresponding to the “bubble” was
observed, even though the fractions from the penultimate pu-
rification step had a preference for junction (data not shown).
2 XPF/ERCC4: in this paper we show that these two proteins are
identical, and hence we will use XPF for the rest of the paper.
FIG. 1. Purification of the XPF-ERCC1 complex. The purified
complex was separated on a 10% SDS-polyacrylamide gel and analyzed
by silver nitrate staining (lane 1, 240 ng) and immunoblotting with
anti-ERCC1 antibodies (lane 2, 40 ng).
FIG. 2. Specific complementation of XP-F, ERCC-1, and
ERCC-4 mutants by the XPF-ERCC1 complex. CFEs from different
repair complementation groups were incubated in the standard reac-
tion mixture in the absence (2) or presence (1) of the purified XPF-
ERCC1 complex (8 ng). Lanes 1 and 2, XP-A (GM02345B); lanes 3 and
4, XP-F (GM08437A); lanes 5 and 6, ERCC-1 (UV20); lanes 7 and 8,
ERCC-3 (UV24); lanes 9 and 10, ERCC-4 (UV41); lanes 11 and 12,
ERCC-5 (UV135). 28 indicates the position of the main excision product.
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The single-stranded DNA-specific S1 nuclease gave a similar
pattern of incision, although the two enzymes differed with
regard to the sequence effect on cleavage within the single-
stranded region. Nevertheless, these results strongly support
the idea that XPF-ERCC1 cleaves M13 DNA and bubble struc-
tures as a single-stranded DNA-specific endonuclease but not
because of its specific attack on stem-loop structures in M13
DNA.
Stimulation of Endonuclease Activity of XPF-ERCC1 Com-
plex by Human RPA—Recent data using anti-ERCC1 anti-
bodies suggested that XPF-ERCC1makes the 59 incision (16) in
the dual incisions of human excinuclease (17). Having found
that XPF-ERCC1 is in fact a single-stranded DNA-specific en-
donuclease, the question arises as to what factors make it
specific for incising damaged DNA only at the 59 site 20–24
nucleotides away from the lesion. Two human excision repair
proteins, XPA and RPA, are known to bind preferentially to
damaged DNA (18, 19). Therefore, we considered the possibility
that either or both of these proteins might target XPF-ERCC1
to damage. When human RPA was added to the nuclease assay
with supercoiled double-stranded DNA, the weak XPF-ERCC1
nicking activity on UV-damaged DNA was stimulated by ;90%
but not on undamaged DNA (Fig. 4B, lane 8). This stimulation
is specifically caused by human RPA because neither yeast
RPA (lane 10) nor E. coli single-stranded DNA binding (SSB)
protein (lane 12) can induce the same effect. On the other hand,
we did not detect any effect of XPA on the nicking activity (data
not shown). The mechanism of stimulation of the XPF-ERCC1
nuclease activity by human RPA is not known at present.
Nevertheless, our data provide some clues as to how the non-
specific nuclease activity of XPF-ERCC1 is made to act specif-
ically with the aid of other excision repair proteins known to be
essential for precise incisions by human excision nuclease.
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